Vaccine for vicious rotavirus
South African children may soon be vaccinated against rotavirus, a deadly virus that is the main cause of severe diarrhoea and vomiting in children under the age of six.
This follows the Medicines Control Council’s registration of an oral rotavirus vaccine produced by GlaxoSmithKline (GSK).
The vaccine’s registration was fast-tracked by the MCC, following an appeal by the company to the health minister.
Rotavirus is a highly infectious disease that causes about 600 000 deaths and 138-million infections a year worldwide, the vast majority in developing countries.
Earlier in the year, the US Advisory Committee on Immunisation Practices recommended that all babies be vaccinated against rotavirus.
Although most parents don’t know the name of the virus, almost all children under the age of three who get a high fever, watery diarrhoea and vomiting are infected with rotavirus, according to health experts.
A recent study at King Edward V Hospital in Durban found that almost a quarter of babies who had died from diarrhoea were infected by the rotavirus.
‘We are delighted that the vaccine has been registered, now we are looking forward to making this life-saving vaccine available to all children that need it in the country,’ said Karim El-Alaoui, Vice-President and GM, GSK Pharmaceuticals, South Africa.
According to the company, over 70 000 babies were involved in the development of the vaccine and studies were conducted in Europe, the US, Africa (including South Africa), Latin America and Asia to evaluate the safety and efficacy of the vaccine.
‘These studies have demonstrated that although the vaccine doesn’t prevent children from getting rotavirus, it substantially reduces suffering,’ said GSK spokesperson Dudu Ndlovu.
The company has initiated talks with the Department of Health to ensure that the vaccine reaches all South African children who need it, she added. ‘ Health-e News Service.
Author
Kerry Cullinan is the Managing Editor at Health-e News Service. Follow her on Twitter @kerrycullinan11
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Vaccine for vicious rotavirus
by Kerry Cullinan, Health-e News
July 19, 2006